DRIO
DarioHealth Corp. NASDAQ Listed Mar 14, 2016$6.15
+1.49%
vs $6.06
Mkt Cap $305.2M
52w Low $5.99
1.4% of range
52w High $17.35
50d MA $7.48
200d MA $10.36
P/E (TTM)
2.7x
EV/EBITDA
—
P/B
4.5x
Debt/Equity
0.5x
ROE
-61.4%
P/FCF
-11.7x
RSI (14)
14.30
ATR (14)
$0.41
Beta
1.28
50d MA
$7.48
200d MA
$10.36
Avg Volume
7.7K
DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Musculoskeletal, which helps to prevent and treat the most common MSK conditions; Dario's behavioral health solution that optimizes access to evidence-based care; chronic condition management solutions; DarioEngage, a proprietary care management platform; and device-specific disposables test strip cartridges, lancets, and blood glucose monitoring systems. It also provides smart glucose meters; bluetooth connected blood pressure cuff; digital scales; biofeedback sensor devices; and diabetes management programs, including lifestyle changes, healthy eating, advanced tracking, and live coaching. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.
18 West 18th Street · New York City, NY 10011 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 13, 2026 | BMO | -1.48 | -1.25 | +15.5% | 8.68 | -7.9% | -6.7% | +3.6% | -1.1% | +0.6% | -1.8% | — |
| Mar 19, 2026 | BMO | -2.44 | -0.80 | +67.2% | 8.24 | -3.2% | -3.0% | -6.1% | +3.5% | -0.8% | +9.7% | — |
| Nov 13, 2025 | BMO | -2.63 | -1.85 | +29.7% | 9.92 | +0.0% | +18.2% | +19.1% | -5.4% | +5.9% | -1.3% | — |
| Aug 12, 2025 | BMO | -2.20 | -2.40 | -9.1% | 8.57 | +5.0% | +5.0% | -3.1% | +2.8% | +0.4% | -2.2% | — |
| May 14, 2025 | BMO | -1.40 | -1.20 | +14.3% | 13.20 | -0.9% | -0.8% | +0.8% | +0.0% | +4.5% | +0.0% | — |
| Mar 10, 2025 | BMO | -3.20 | 0.20 | +106.2% | 13.42 | -0.1% | -7.3% | +1.3% | +2.9% | +2.7% | +3.0% | — |
| Nov 7, 2024 | BMO | -3.60 | -2.60 | +27.8% | 19.40 | +0.0% | -5.2% | -3.3% | -2.8% | -0.2% | -6.6% | — |
| Aug 8, 2024 | BMO | -5.80 | 1.20 | +120.7% | 16.70 | +2.4% | -5.3% | +20.8% | -4.3% | +0.1% | -4.9% | — |
| May 15, 2024 | BMO | -11.80 | -4.00 | +66.1% | 37.00 | -1.6% | +1.6% | +1.1% | -7.4% | +2.8% | -3.9% | — |
| Mar 28, 2024 | BMO | -10.80 | -8.20 | +24.1% | 30.60 | -0.7% | -3.3% | -10.1% | +7.5% | -3.5% | -2.2% | — |
| Nov 2, 2023 | BMO | -10.00 | -9.80 | +2.0% | 20.20 | +5.0% | +32.7% | -3.0% | +0.0% | -7.7% | -10.0% | — |
| Aug 10, 2023 | BMO | -10.40 | -11.60 | -11.5% | 63.00 | -1.0% | +0.3% | +0.3% | -11.0% | -6.0% | -1.9% | — |
| May 11, 2023 | AMC | -9.20 | 9.00 | +197.8% | 77.20 | -0.5% | +3.9% | -5.5% | -0.3% | -1.6% | +1.3% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 20 | Stifel | Maintains | Buy → Buy | — | $8.24 | $7.98 | -3.2% | -3.0% | -6.1% | +3.5% | -0.8% | +9.7% |
| Mar 11 | Stifel | Maintains | Buy → Buy | — | $13.42 | $13.40 | -0.1% | -7.3% | +1.3% | +2.9% | +2.7% | +3.0% |
| Apr 1 | Stifel | Maintains | Buy → Buy | — | $30.60 | $30.40 | -0.7% | -3.3% | -10.1% | +7.5% | -3.5% | -2.2% |
| Aug 11 | Alliance Global Partners | Maintains | Buy → Buy | — | $63.00 | $62.40 | -1.0% | +0.3% | +0.3% | -11.0% | -6.0% | -1.9% |
| Jul 25 | Stifel | Maintains | Buy → Buy | — | $73.80 | $74.00 | +0.3% | -6.2% | +4.3% | -2.8% | +6.6% | -0.3% |
| May 12 | Craig-Hallum | Maintains | Buy → Buy | — | $77.20 | $76.80 | -0.5% | +3.9% | -5.5% | -0.3% | -1.6% | +1.3% |
| Nov 16 | Alliance Global Partners | Maintains | Buy → Buy | — | $98.20 | $95.80 | -2.4% | +5.1% | +1.4% | -2.3% | -6.8% | +0.2% |
| Aug 18 | Aegis Capital | Maintains | Buy → Buy | — | $109.80 | $108.60 | -1.1% | -6.9% | -4.1% | +7.6% | -1.1% | -0.2% |
| Aug 16 | TD Cowen | Maintains | Outperform → Outperform | — | $134.80 | $133.20 | -1.2% | -13.1% | -6.3% | -6.9% | -4.1% | +7.6% |
| May 16 | Aegis Capital | Maintains | Buy → Buy | — | $117.20 | $116.00 | -1.0% | +11.4% | +10.1% | -10.3% | -1.2% | -2.8% |
| May 16 | TD Cowen | Maintains | Outperform → Outperform | — | $117.20 | $116.00 | -1.0% | +11.4% | +10.1% | -10.3% | -1.2% | -2.8% |
| May 13 | Alliance Global Partners | Upgrade | Neutral → Buy | — | $103.60 | $93.00 | -10.2% | +13.1% | +11.4% | +10.1% | -10.3% | -1.2% |
| Jan 26 | Aegis Capital | Maintains | Buy → Buy | — | $172.20 | $176.40 | +2.4% | -4.3% | -3.9% | +5.7% | +4.8% | +0.0% |
| Aug 19 | Aegis Capital | Maintains | Buy → Buy | — | $219.20 | $219.40 | +0.1% | -4.1% | +7.8% | +1.8% | +6.8% | -0.7% |
| Apr 22 | TD Cowen | Maintains | Outperform → Outperform | — | $344.40 | $360.40 | +4.6% | +7.4% | +0.3% | +12.9% | -4.7% | +9.1% |
| Mar 23 | Stifel | Maintains | Buy → Buy | — | $484.40 | $493.00 | +1.8% | -6.3% | -12.8% | +4.8% | +0.0% | -7.3% |
| Feb 8 | Aegis Capital | Maintains | Buy → Buy | — | $499.80 | $515.40 | +3.1% | +8.5% | +3.3% | +3.2% | +4.0% | +1.2% |
| Nov 25 | Craig-Hallum | Maintains | Buy → Buy | — | $254.60 | $254.60 | +0.0% | +1.4% | -0.2% | -2.6% | -0.9% | -1.4% |
| Nov 25 | Aegis Capital | Maintains | Buy → Buy | — | $254.60 | $254.60 | +0.0% | +1.4% | -0.2% | -2.6% | -0.9% | -1.4% |
| Nov 25 | ThinkEquity | Maintains | Buy → Buy | — | $254.60 | $254.60 | +0.0% | +1.4% | -0.2% | -2.6% | -0.9% | -1.4% |
| Aug 17 | Aegis Capital | Maintains | Buy → Buy | — | $330.00 | $330.00 | +0.0% | +13.2% | +0.4% | +10.1% | -2.2% | -7.9% |
| Jun 22 | ThinkEquity | Maintains | Buy → Buy | — | $130.60 | $136.00 | +4.1% | +1.7% | -2.1% | -1.8% | -1.3% | -1.6% |
| May 13 | Craig-Hallum | Maintains | Buy → Buy | — | $140.00 | $142.40 | +1.7% | -1.4% | -0.7% | +1.5% | -1.3% | +2.0% |
| Jun 6 | Craig-Hallum | Maintains | Buy → Buy | — | $192.00 | $204.00 | +6.2% | +2.5% | -2.4% | +14.4% | -7.6% | -5.4% |
| Apr 9 | Chardan Capital | Maintains | Buy → Buy | — | $628.00 | $652.00 | +3.8% | +5.7% | +1.2% | -0.6% | +3.0% | +2.3% |
| Aug 29 | Aegis Capital | Maintains | Buy → Buy | — | $800.00 | $808.00 | +1.0% | +6.5% | +2.3% | -3.7% | -6.7% | -4.1% |
| May 9 | Rodman & Renshaw | Maintains | Buy → Buy | — | $2160.00 | $2300.00 | +6.5% | +1.5% | -2.0% | +0.9% | -5.0% | +6.2% |
No insider trades available.
8-K
Unknown — 8-K Filing
I need the complete filing information to provide an accurate analysis. The summary appears incomplete and doesn't clearly specify which company (DRIO, LUCD, or PAVM) filed what action, making it impossible to assess the material impact on shareholders.
Apr 13
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
A new executive with deep healthcare operations and Medicare expertise from Fortune 50 Centene and successful acquisition experience joins leadership, potentially signaling strategic shifts in health plan operations or population health initiatives for these companies.
Apr 9
8-K
Unknown — 8-K Filing
DRIO's offering proceeds will primarily fund debt repayment and working capital, reducing financial flexibility for growth investments and potentially signaling cash constraints.
Mar 30
8-K · 5.03
! Medium
DarioHealth Corp. -- 8-K 5.03: Amendment to Articles / Bylaws
DarioHealth Corp. (DRIO) shifted its fiscal year-end, which may affect financial reporting timelines and comparability with prior periods for investors monitoring earnings announcements.
Feb 2
Institutional (13F) — Top 10
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Vanguard Capital Management Llc | 65,910 | $529K | New | Mar 2026 |
| 2 | Citadel Advisors Llc | 20,460 | $164K | New | Mar 2026 |
| 3 | Ubs Group Ag | 15,901 | $128K | Added | Mar 2026 |
| 4 | Northern Trust Corp | 13,237 | $106K | New | Mar 2026 |
| 5 | Royal Bank Of Canada | 448 | $3K | Added | Mar 2026 |
| 6 | Trust Co Of Toledo Na /oh/ | 352 | $3K | — | Mar 2026 |
| 7 | Steward Partners Investment Advisory, Llc | 10 | $80 | — | Mar 2026 |
| 8 | Bnp Paribas Financial Markets | 9 | $72 | — | Mar 2026 |
| 9 | Wells Fargo & Company/mn | 5 | $40 | New | Mar 2026 |
| 10 | Jpmorgan Chase & Co | 1 | $8 | — | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 7
All ↗
| # | Fund | Shares | Value | Period |
|---|---|---|---|---|
| 1 | Fidelity Extended Market Index Fund | 30,991 | $371K | Feb 2026 |
| 2 | Fidelity Series Total Market Index Fund | 7,756 | $93K | Feb 2026 |
| 3 | Fidelity Total Market Index Fund | 7,626 | $91K | Feb 2026 |
| 4 | U.S. CORE EQUITY 2 PORTFOLIO | 911 | $9K | Jan 2026 |
| 5 | U.S. MICRO CAP PORTFOLIO | 200 | $2K | Jan 2026 |
| 6 | Dimensional U.S. Small Cap ETF | 51 | $511 | Jan 2026 |
| 7 | U.S. SMALL CAP PORTFOLIO | 17 | $170 | Jan 2026 |
Valuation
Market Cap
$305.2M
Enterprise Value
$309.7M
P/E (TTM)
2.73x
Forward P/E
—
PEG Ratio
0.05x
P/B
4.49x
P/S
14.40x
P/FCF
-11.70x
EV/EBITDA
—
Shares Out
49.6M
Financials (TTM)
Revenue
$21.2M
Net Income
$62.7M
EBITDA
-$32.2M
Free Cash Flow
-$26.1M
Op Cash Flow
-$25.9M
EPS Basic
$1.24
EPS Diluted
$2.25
EPS Forward
$-4.88
Gross Margin
56.5%
Op Margin
-251.9%
Net Margin
295.9%
Balance Sheet
Total Assets
$110.1M
Total Liab.
$42.2M
Total Equity
$67.9M
Cash
$26.2M
LT Debt
$30.7M
Book Value/Sh
$1.37
Debt/Equity
0.47x
Current Ratio
3.73
Quick Ratio
3.27
Returns & Growth
ROE
-61.4%
ROA
-37.9%
ROIC
-36.2%
Rev Growth YoY
-17.3%
EPS Growth YoY
+267.6%
Price Returns
2W
-7.6%
1M
+8.4%
3M
-35.3%
6M
-35.1%
12M
-45.8%
Technicals
52W High
$17.35
52W Low
$5.99
50d MA
$7.48
200d MA
$10.36
RSI (14)
14.30
ATR (14)
$0.41
Beta
1.28
Avg Volume
8K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$16.00
High
$16.00
Low
$16.00
Median
$16.00
Data updated apr 25, 2026 5:46am
· Source: financialmodelingprep.com